Cardiovascular Clinical Studies

This channel includes news and new technology innovations from cardiovascular clinical trials. These clinical studies include all cardiac subspecialties.

Bicêtre Hospital in Paris, France, and Baptist Stroke & Cerebrovascular Center in Jacksonville, Florida, USA, join global network of leading stroke centers as part of WE-TRUST multicenter clinical trial to evaluate the potential benefits of a Direct to Angio Suite treatment pathway for stroke patients

News | Stroke

First Patients in France and the USA Enrolled in Global WE-TRUST Trial to Accelerate Stroke Diagnosis and Treatment

July 20, 2023 — The first patients in France and the USA have been enrolled into the large-scale WE-TRUST* multicenter ...

July 20, 2023

The proposed approach outperforms other neural network architectures by leveraging rich geometric information to segment brain stroke lesion images

News | Stroke

New Geometric Deep Learning Model for Detecting Stroke Lesions

July 19, 2023 — Ischemic stroke, which occurs when a blood vessel in the brain gets blocked by a clot, is among the ...

July 19, 2023

A new clinical study in Europe examines the applicability and effectiveness of the new TIMELY Platform for telemedical secondary prevention

News | Artificial Intelligence

AI-Supported Telemedicine Platform Aims to Improve the Health of Patients After Myocardial Infarction and Prevent Reinfarctions

July 18, 2023 — The TIMELY consortium announced today the enrollment of the first patient in the randomized controlled ...

July 18, 2023

No statistical difference observed across sub-analyses for diabetes, lesion length, calcium, bailout stenting and occlusions in head-to-head study comparing Passeo-18 Lux DCB to In.Pact Admiral DCB

News | Drug-Eluting Balloons

BIOPACT RCT Subgroup Analyses Show Consistently Great Results for Passeo-18 Lux Drug-Coated Balloon

July 14, 2023 — BIOTRONIK announced the one-year subgroup results from the investigator-initiated BIOPACT randomized ...

July 14, 2023

Illustration for the deployment and shaping process of the occluder.

News | Structural Heart Occluders

Transcatheter Closure of Perimembranous Ventricular Septal Defect Using a Novel Fully Bioabsorbable Occluder: Multicenter Randomized Controlled Trial

July 14, 2023 — In recent years, transcatheter intervention techniques have emerged as a promising alternative for the ...

July 14, 2023

A subgroup analysis of the HOST-IDEA randomized controlled trial showed efficacy differences of Ultrathin Strut DES

News | Stents Drug Eluting

Late-Breaking Study Data: BIOTRONIK’s Orsiro DES Outperforms Other Ultrathin Strut Drug-Eluting Stent

July 12, 2023 — In a late breaking trial session during EuroPCR 2023 in Paris, on behalf of the HOST-IDEA study ...

July 12, 2023

US study seeking to confirm strong efficacy data reported in RED DESERT and SAHARA

News | Heart Failure

Sequana Medical Announces First Patient Enrolled in MOJAVE

July 10, 2023 — Sequana Medical NV, a pioneer in the treatment of fluid overload in liver disease, heart failure and ...

July 10, 2023

Coronary computed tomography angiography is a cheaper, less-invasive alternative to intravascular ultrasound in pharmaceutical clinical trials

Feature | Cardiac Imaging | By Matthew Jay Budoff, MD, FACC, FAHA

The Benefits of Coronary CTA in Pharmaceutical Clinical Trials

Coronary computed tomography angiography (CCTA) is cheaper, easier to use and its results are easier to understand than ...

July 10, 2023

Atrial fibrillation (AFib) is the most common type of heart arrhythmia. This serious condition occurs when the heart beats so fast that the upper chambers of the heart quiver. This irregular heartbeat can lead to severe conditions, including heart failure, dementia and a fivefold increase in the risk of stroke

News | Atrial Fibrillation

Reduced Levels of FKBP5 Promote Atrial Fibrillation

July 7, 2023 — Atrial fibrillation (AFib) is the most common type of heart arrhythmia. This serious condition occurs ...

July 07, 2023

UM School of Medicine faculty develop tool to assess risks earlier in vulnerable patients

News | Cardiovascular Clinical Studies

New Study Highlights Dangers of Cumulative Exposure to Cardiovascular Risks and Need for Earlier Primary Prevention Strategies

July 5, 2023 — With heart disease the most common cause of death worldwide, researchers have attempted to quantify how ...

July 05, 2023

Preferential use of pulmonary MR angiography (MRA) for diagnosing pulmonary embolus (PE) in the general population helped conserve iodinated contrast media during the 2022 shortage

News | Contrast Media

Switch to MR Angiography for PE Mitigated Impact of Recent Contrast Shortage

July 3, 2023 — According to an accepted manuscript published in ARRS’ own American Journal of Roentgenology (AJR) ...

July 03, 2023

UNC School of Medicine scientists Whitney Edwards, Ph.D., Frank Conlon, Ph.D., and colleagues identified molecular pathways critical for heart development.

News | Congenital Heart

Researchers Target Proteins, Pathways Behind Congenital Heart Disease

July 3, 2023 — Researchers at the UNC School of Medicine, UNC McAllister Heart Institute, and the UNC Lineberger ...

July 03, 2023

Approval based on two positive Phase 3 trials, EXPLORER-HCM and VALOR-HCM, demonstrating significant benefit in patients treated with CAMZYOS versus placebo

News | Pharmaceuticals

Bristol Myers Squibb Receives European Commission Approval of CAMZYOS (mavacamten), for the Treatment of Symptomatic Obstructive Hypertrophic Cardiomyopathy (HCM)

June 28, 2023 — Bristol Myers Squibb announced that the European Commission (EC) has approved CAMZYOS (mavacamten, 2.5 ...

June 28, 2023

Global clinical study aims to broaden evidence base by assessing clinical and economic benefits for the FFRangio System

News | FFR Technologies

CathWorks Announces First Patient Enrolled in Global ALL-RISE Study

June 28, 2023 — CathWorks announced that the first patient has been enrolled in the Advancing Cath Lab Results with FFRa ...

June 28, 2023

This study aimed to evaluate the association between LDL-C levels, post-stroke infection and all-cause mortality. 804,855 ischemic stroke patients were enrolled.

News | Stroke

U-shaped Association Between Low-density Lipoprotein Cholesterol Levels and Risk of All-cause Mortality Mediated by Post-stroke Infection in Acute Ischemic Stroke

June 28, 2023 — The general perception supports the mantra of “lower is better” for low-density lipoprotein cholesterol ...

June 28, 2023